Liliane Min, M.D., Peter Barland, M.D., and Elena Peeva, M.D.
Dr. Min is a Fellow in Rheumatology and Dr. Peeva is Assistant Professor of Medicine, both at The Albert Einstein College of Medicine, New York.
Within the past 12 months, Dr. Peeva has received grant support from Immunomedics. Drs. Min and Barland report no commerical conflicts of interest.
Release Date: 03/20/2006
Termination Date: 03/20/2009
Estimated time to complete: 1 hour(s).
Albert Einstein College of Medicine designates this enduring material for a maximum of 1
AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Albert Einstein College of Medicine is accredited
by the Accreditation Council for Continuing
Medical Education to provide continuing medical
education for physicians.
 
Learning Objectives
Upon completion of this Cyberounds
®, the participant should be able to:
- Discuss the B cell-depleting therapies for SLE now undergoing clinical trials
- Discuss the B cell-stimulating cytokines for SLE now undergoing clinical trials
- Discuss the safety profile of the above treatments.